CAR-T has shown remarkable success in treating blood cancers like acute lymphoblastic leukemia and large B-cell lymphoma. By engineering a patient’s own immune cells, it delivers highly targeted therapy, often achieving remission where traditional treatments may have failed. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/